







In this article, we review the literature regarding prenatal cocaine exposure and child de-
velopment. We then reexamine current child welfare policies in light of that literature,
paying particular attention to laws that mandate reporting substance-exposed newborns
and substance use during pregnancy as well as policies that view such reports as prima facie
evidence of child maltreatment. Finally, we reassess the utility of such policies, given our
current knowledge of the long-term effects of prenatal exposure, and consider alternative
approaches to protecting children who are born to parents who are using crack cocaine.
The ‘‘crack epidemic’’ that began in the mid-1980s has been associated
with an increase in the number of children exposed to cocaine in utero.
The Office of the Inspector General estimates that 100,000 children are
born prenatally exposed to crack cocaine each year (Hawley et al. 1995);
others have estimated this figure to be somewhere between 40,000 and
375,000 (Mayes and Bornstein 1995).1
Widespread use of the drug has also resulted in an increased number
of children in the child welfare system (Besharov 1990; National Associa-
tion of Public Welfare Administrators [NAPCWA] 1991; Barth 1994; Sa-
bol 1994). Following decreases in the early 1980s, the number of chil-
dren in foster care rose sharply in the late 1980s. Studies of several large
states have indicated that drug use by parents was a leading reason for
the increase in placements; studies have also found a direct relationship
between cocaine use and prenatal exposure and reports to child protec-
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tive services (CPS).2 This latter relationship is not surprising given that
several states have legislation making prenatal exposure to cocaine a
mandatory report to CPS.
Although children exposed prenatally to crack cocaine—so-called
crack babies—are just the tip of the iceberg of the broader class of chil-
dren who are affected by their parents’ substance abuse (Gardner and
Young 1997), they are the most visible and the most reported group.3
The fact that a newborn can be tested to determine his or her mother’s
recent substance use provides a unique opportunity to identify a child
affected by parental substance use. In addition, both the mandatory re-
porting laws in place in several states and explicit policies governing the
acceptance of reports of substance-exposed children as prima facie cases
of child maltreatment in other states have made the period immediately
following birth an opportune time to report a family to CPS. Moreover,
many professionals involved in substance-abuse treatment believe that a
child’s birth is a critical moment for intervention with the user, a mo-
ment when she is most likely to be motivated to pursue treatment. In
short, while parental cocaine use affects children of all ages, it is new-
borns who have been increasingly likely to be referred to CPS and placed
in foster care as a result of the crack epidemic.4 Children under 1 year
old accounted for 23 percent of all children entering care in 1994, com-
pared to only 12 percent in 1977 (U.S. Department of Health and Hu-
man Services 1997; see also Goerge and Wulczyn 1998/99).
The impact of prenatal cocaine exposure on infants has been exten-
sively studied. However, recent reviews of the literature show that much
of the research to date has been found to be contradictory, unreliable,
biased, or inconclusive. We know the least about the long-term effects of
prenatal exposure. Studies that follow prenatally exposed children into
their preschool and school-age years are only now becoming available,
and they have tended not to support many of the assumptions that were
previously made about the developmental limitations of children prena-
tally exposed to cocaine (Robins and Mills 1993; Barth 1994; Zuckerman
1994; Hawley et al. 1995; Needlman et al. 1995; Frank et al. 1996; Lester
et al. 1996; Mayes 1996; Lester, LaGasse, and Bigsby 1998). Such substan-
tial gaps in the literature point to a lack of information with which to
accurately predict the long-term effects of prenatal exposure on chil-
dren’s growth and development.
In this article, we review the current literature regarding the effects of
prenatal cocaine exposure on child development and reexamine cur-
rent child welfare policies in light of the findings from that literature. We
consider, in particular, laws that mandate reporting substance-exposed
newborns and substance use during pregnancy as well as policies that
accept such reports as prima facie evidence of child maltreatment. These
laws and policies have been the popular response to the dilemma of how
to handle crack-exposed children. In light of the current evidence, we
reassess their utility and consider other approaches to the problem of
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protecting children who are born when their parents are using crack
cocaine. While we primarily focus on children who are prenatally ex-
posed to crack cocaine, our discussion of screening, testing, and social
policies relating to prenatal exposure to cocaine may have broader im-
plications for addressing parental substance abuse in general.
Review of Current Literature
Myths and Media Monsters
When the use of crack cocaine first came to public attention, many ob-
servers predicted ‘‘bleak futures’’ for crack-exposed children, assuming
that they would be ‘‘seriously impaired,’’ ‘‘difficult to manage,’’ and
would suffer considerable medical complications as a result of their ex-
posure (Hawley et al. 1995, p. 364). Media reports, often based on non-
scientific and anecdotal evidence, presented the children as both help-
less and hopeless and resulted in widespread myths about these children
and their developmental possibilities. The following passages are typical
of how these children were portrayed in major media outlets in the late
1980s and early 1990s:
One of the infants in the sterile hospital room wailed disconsolately, frantically
flailing its tiny arms and legs as children born to crack-using mothers often do
(Treaster 1993, p. 1; emphasis added).
He sometimes erupts into frenzied episodes of thrashing about, pulling his hair,
biting and banging his head against a wall (Toufexis 1991, p. 58).
[He] has spent his whole life crying. He is jittery and goes into spasms when he is
touched. His eyes don’t focus. He can’t stick out his tongue, or suck (Newsweek,
July 28, 1986; cited in Myers, Olson, and Kaltenbach 1992, p. 2).
[He] has been awake for days. He cries inconsolably, and his tiny limbs jerk and
jitter constantly. Periodically, his hands fly back to the sides of his head and his
large, dark eyes freeze wide in startled terror (Readers Digest, February 1991; cited
in Myers et al. 1992, p. 2).
The ‘‘crack-baby’’ label came to imply that prenatally exposed children
faced devastating developmental prognoses and would fare poorly in
school and later life (Daley 1991; Griffith 1992; Mayes et al. 1992; Zuck-
erman and Frank 1992; Zuckerman 1994; Zuckerman and Frank 1994;
Hawley et al. 1995). The sense that crack-exposed children’s futures were
determined by their prenatal exposure was so strong that these children
were even referred to as a ‘‘bio-underclass.’’ 5
As the first cohort of crack-exposed children began reaching school
age, the media reported that they were ‘‘presenting problems that have
left many kindergarten teachers confused and exhausted’’ (Daley 1991,
p. A1). One teacher was described as being so frustrated with a crack-
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exposed second grader that she threatened to resign if the child was not
removed from her classroom (Sluder, Kinnison, and Cates 1996/97).
Other teachers predicted that if crack-exposed children were placed in
regular classrooms, they would ‘‘kill somebody’’ or ‘‘hurt everybody’’
(Cohen and Erwin 1994, p. 246).
Many of these reports, myths, and assumptions were largely conceived
before crack-exposed children reached school age, and they have yet to
be supported by empirical research. Indeed, researchers in the 1990s
began to challenge many of the early assumptions about prenatally ex-
posed children. In particular, recent research has challenged three com-
mon yet erroneous assumptions: (l) that all prenatally exposed children
are severely affected by exposure, (2) that little can be done to help these
children, and (3) that their medical, behavioral, and learning problems
are directly caused by prenatal exposure (Griffith 1992).
In contrast to what was initially thought, it now appears that a consid-
erable proportion of the outcomes associated with prenatal exposure
can be overcome through competent caregiving in appropriate environ-
ments. Recent studies have concluded that postnatal environmental fac-
tors may play a crucial role in influencing developmental outcomes by
either helping exposed children to overcome biological vulnerabilities
or by placing them at greater risk of harm (see, e.g., Mathias 1992; Zuck-
erman and Frank 1992; Azuma and Chasnoff 1993). Prenatally exposed
children who receive warm and responsive care and are nurtured in sup-
portive environments seem to be able to develop well (Mathias 1992;
Zuckerman and Frank 1992). Conversely, children whose mothers con-
tinue to use crack cocaine after their births may be at substantially ele-
vated risk of poor development, in large part due to the adverse effects
of living with an addicted mother.
Finally, many of the outcomes that were once attributed solely to pre-
natal exposure to crack cocaine have recently been linked to both con-
founding variables and methodological shortcomings in the studies
themselves. It now appears that previous studies have tended to over-
estimate the effects of prenatal exposure on newborns as well as its long-
term effects on children’s growth and development (Lutiger et al. 1991;
Chasnoff et al. 1992; Mayes et al. 1992; Hutchings 1993; Frank et al.
1996).6
Methodological Issues
The extent to which children are affected by crack exposure in utero is
difficult to determine for several reasons. First, the vast majority of chil-
dren who are prenatally exposed to crack cocaine have also been pre-
natally exposed to alcohol, tobacco, or other drugs, each of which may
contribute to some of the outcomes that are sometimes solely attributed
to crack exposure (Lutiger et al. 1991; Hutchings 1993; Richardson and
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Day 1994; Hawley et al. 1995; Lester et al. 1996; Lester, LaGasse, and
Bigsby 1998). Yet many studies have not controlled for prenatal use of
other substances.
Second, there is an interplay between prenatal exposure and adverse
socioeconomic circumstances, including poverty, poor home environ-
ments, and other factors that may contribute to poor outcomes for chil-
dren (van Baar 1990; Kliegman et al. 1994; Richardson and Day 1994).7
Observers have criticized studies on the grounds that they have not been
able to separate the effects of prenatal exposure from those of lack of
prenatal care, poor maternal health, inadequate prenatal nutrition, so-
cial disadvantage, and other correlates of poverty (Chasnoff 1992; Chas-
noff et al. 1992; Robins and Mills 1993; Zuckerman and Frank 1994; Haw-
ley et al. 1995; Lester, Freier, and LaGasse 1995; Mayes and Bornstein
1995; Neuspiel 1995; Olson et al. 1995; Frank et al. 1996; Hans 1996;
Lester et al. 1996; Mayes 1996). These factors, coupled with the fact that
poor and black women are much more likely to be identified as prenatal
users than are white middle- and upper-class women, have meant that
the children studied have tended to be at elevated risk for negative peri-
natal outcomes for many reasons other than the direct effect of their
prenatal exposure to cocaine (Kliegman et al. 1994; Richardson and Day
1994).8
A third limitation is that studies have not been able to completely
control for other ‘‘lifestyle issues’’ that result when a pregnant woman is
living in, and a child is born into, a ‘‘drug-seeking environment’’ of
‘‘chaos and flux’’ (Chasnoff 1992, p. 307). In their interviews with crack-
addicted mothers, Hawley et al. (1995) found that many of the women
reported that they were negligent or dysfunctional caregivers when using
drugs. The following passages illustrate their responses: ‘‘I didn’t care
about nothin’ but how I was going to get [drugs]. I didn’t supply their
needs too good. I didn’t wash their clothes, I didn’t do nothin’ I was sup-
posed to do when I was usin’.’’ ‘‘I would more or less push them aside,
um, be mean to them, you know, ’cause I didn’t want them around
me. . . . I didn’t want them to see me doin’ what I was doin’ ’’ (Hawley
et al. 1995, p. 372).9
Fourth, a variety of methodological concerns have been raised relating
to studies of this population. Possible undetected exposure of control
group infants and children may threaten the validity of results, particu-
larly for those studies that rely on either maternal self-reports or urine
testing to document exposure. Self-reported patterns of use are difficult,
if not impossible, to verify. Urine testing, which, in conjunction with self-
report, is the most common detection method used, detects only cocaine
metabolites within 48–72 hours of use, providing little information
about dosage, frequency, and chronicity of use. Meconium testing can
be used to reveal use in the more distant past (back to 20-weeks gesta-
tional age) but has been much more rarely used (Chasnoff 1992; Barth
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and Needell 1996; Frank et al. 1996).10 When self-report or urine tests
are employed to identify prenatally exposed children, control groups
may include children who were exposed days, weeks, or months before
their mothers were tested as well as those exposed children whose moth-
ers deny using. Such undetected exposure in control groups may limit
any observable developmental differences between exposed and (sup-
posedly) nonexposed children, resulting in an underestimation of the
negative effects of prenatal exposure. In addition, many current studies
focus on experimental group children whose mothers participated in
substance-abuse treatment or stopped using cocaine during the study pe-
riod—factors that could influence results by reducing the amounts and,
therefore, observable effects of exposure (Chasnoff et al. 1992; Azuma
and Chasnoff 1993; Hawley et al. 1995).11
Conversely, difficulties controlling for dosage, other drug use, route
and timing of administration, and passive postnatal exposure (factors
that have further prevented researchers from firmly linking specific de-
velopmental outcomes to the timing and amounts of prenatal exposure)
suggest that some studies may have resulted in overestimations of the
adverse developmental effects of prenatal exposure. Finally, the gener-
alizability of studies of prenatally exposed children has also been limited
by inadequate or inconsistent measures and study designs, sample selec-
tion biases, sampling and measurement problems, high rates of attrition,
and small sample sizes (Chasnoff 1992; Robins and Mills 1994; Zucker-
man and Frank 1994; Hawley et al. 1995; Lester et al. 1995; Neuspiel
1995; Olson et al. 1995; Frank et al. 1996; Lester et al. 1996; Mayes 1996;
Lester, LaGasse, and Bigsby 1998).
What Have We Learned?
Keeping in mind the potentially confounding effects of environmental
and socioeconomic factors, as well as the methodological problems sum-
marized above, what can we conclude about the effects of cocaine expo-
sure in utero on subsequent child development? Most studies have fo-
cused on newborns and tend to find that cocaine-exposed infants are
more likely than others to be born prematurely and to exhibit low birth
weight, decreased length, and small head circumference (Chasnoff et al.
1989; Chasnoff et al. 1992; Azuma and Chasnoff 1993; Kliegman et al.
1994).12 It is unclear, however, whether these effects are lasting. While
some studies have reported that prenatal exposure to crack permanently
affects growth, others have found no permanent effects. For example, a
study conducted by Ira Chasnoff and colleagues found that exposed in-
fants who exhibited low birth weight and decreased length caught up to
control infants on these factors by age 1 (Chasnoff et al. 1992; Azuma
and Chasnoff 1993).
Evidence regarding the effects of cocaine exposure on other infant
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outcomes is much less certain. Although prenatal exposure has, particu-
larly in earlier studies, sometimes been associated with spontaneous
abortion, abruptio placentae, intrauterine growth retardation, intraven-
tricular hemorrhage, abnormal growth patterns, apnea, sudden infant
death syndrome, genitourinary tract malformations, and neurobehav-
ioral deficiencies, each of these effects may be confounded by other sub-
stance use, poor nutrition, and poor prenatal care (Hutchings 1993;
Robins and Mills 1994). Cocaine exposure in utero has also been linked
to poorer outcomes for infants (and sometimes toddlers) in terms of
organizational skills, language development, congenital malformation
and perinatal mortality, emotional and behavioral functioning, visual
recognition memory, neurobehavioral capabilities, attachment and peer
relations, interactive abilities, self-regulation capacities, responses to ex-
ternal stimuli, cognitive development, and motor development/motor
coordination (Chasnoff et al. 1985; Chasnoff et al. 1989; van Baar 1990;
Chasnoff et al. 1992; Hansen, Struthers, and Gospe 1993; Singer et al.
1994; Beckwith et al. 1995; Hawley et al. 1995; Barth and Needell 1996;
Bayer et al. 1996; Calhoun and Alforque 1996; Johnson et al. 1997; Les-
ter, LaGasse, and Bigsby 1998). Such outcomes, however, have not been
consistently observed, and these findings have largely been challenged
by later studies.13 Recent studies have found that, controlling for socio-
economic variables and other drug use, (1) prenatal cocaine exposure
appears not to significantly affect infant growth and morphology (Rich-
ardson and Day 1994), and (2) even the most impaired cocaine-exposed
infants do not differ behaviorally from other neurologically impaired in-
fants (Schutter and Brinker 1992).
Fewer studies have followed cocaine-exposed children beyond infancy.
We could find only 12 studies that followed children beyond the first year
of life and only nine that followed children to age 3 or higher. Despite
sharing some of the same limitations as many of the infant studies, these
longitudinal studies have the advantage of tracking children’s develop-
ment over time. Thus they should be given more weight when consider-
ing the evidence regarding the long-term effects of prenatal exposure to
crack cocaine. Although these longitudinal studies report mixed results,
our review of the evidence below suggests that there are indeed links be-
tween prenatal exposure to cocaine and later developmental problems.
Some of these studies found essentially no long-run effects of prenatal
exposure to cocaine. Laura Guisti’s (1996) study of exposed and nonex-
posed foster children ranging in age from 12 to 28 months found no
significant developmental differences between the two groups, although
both groups exhibited developmental scores that were below the na-
tional norm. Ellen Franck (1996) studied children under 5 years old in
out-of-home care in New York City and concluded that the prenatally
exposed children in her sample did not significantly differ from nonex-
posed children in terms of developmental delays. Scott Azuma and Chas-
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noff followed a group of cocaine-exposed children, and non-exposed
controls, to age 3. The cocaine-exposed infants were found to have
smaller head circumferences at birth and at 18 months of age, but cog-
nitive development did not differ between the two groups at 18 months
nor were there any significant differences in developmental outcomes
between the exposed and control children at age 2 or age 3 (Azuma and
Chasnoff 1993).
However, most of the longitudinal studies have found at least some
long-run effects of prenatal cocaine exposure or have noted that the ef-
fects may have been too subtle for them to capture. For instance, in their
study of exposed and nonexposed foster children between the ages of 1
and 4, Kimberly Yolton and Rosemary Bolig (1994) found that the two
groups did not differ in terms of temperament, play behaviors, or adapt-
ive behaviors. However, the exposed children in this study scored lower
than controls in terms of conceptual development, and they displayed
more physically violent behaviors. Hawley et al. (1995) report that the
exposed children in their studies presented generally normal scores re-
lated to overall development and exhibited few differences from nonex-
posed children in terms of cognitive and language development through
age 5, but the researchers caution that there may have been differences
not detected by their developmental measures. The exposed children,
for instance, required more sessions to complete the developmental as-
sessment because they seemed easily distracted and required coaxing to
engage in the test activities.
Barry Lester and his colleagues note in their 1998 review that of the
five studies using standardized tests to track cognitive development in
cocaine-exposed children ages 3– 6, only one found significant differ-
ences between cocaine-exposed children and nonexposed controls (and
that study was conducted in the Netherlands on a population of children
whose mothers had used heroin and methadone in addition to cocaine)
(Lester, LaGasse, and Bigsby 1998).14 However, they found more evi-
dence related to impaired language development. Of the seven studies
that included a language assessment of children ages 3– 6, five found
statistically significant differences between cocaine-exposed and nonex-
posed children, with exposed children performing more poorly (Ange-
lilli et al. 1994; Malakoff, Mayes, and Shottenfeld 1994; Nulman et al.
1994; van Baar and de Graaff 1994; Bender et al. 1995). These longer
term, follow-up studies also provide some evidence that exposed chil-
dren differ from nonexposed children regarding visual motor integra-
tion and sustained attention to tasks (Bender et al. 1995; Hawley et al.
1995; Richardson, Conroy, and Day 1996). Such findings led Lester and
his colleagues to conclude that ‘‘as a group, children who have been
exposed prenatally to cocaine are heterogeneous, displaying no consis-
tent patterns of developmental deficiency. In fact, many function well
within the average range for intelligence and adaptive skills. Differences
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in their development seem to cluster around attention, language com-
prehension, and emotional and behavioral regulation’’ (Lester, LaGasse,
and Bigsby 1998, p. 139).15
Most recently, Chasnoff and colleagues’ (1998) longitudinal study
(completed after the review by Lester, LaGasse, and Bigsby [1998]) con-
cluded that behavioral characteristics of 4 – 6 year olds were directly af-
fected by prenatal exposure, resulting in higher rates of depression and
anxiety; social, thought, and attention problems; delinquent and aggres-
sive behaviors; and impulsivity and distractibility among prenatally ex-
posed children. In terms of cognitive effects, the researchers found that
while prenatal exposure did not directly affect the IQ scores of these
children, their IQ scores were indirectly affected through the quality of
their home environments: children living in homes in which there was
prenatal substance use had poorer quality home environments, a factor
that was related to lower IQ scores (Chasnoff et al. 1998).
Although the effects of cocaine exposure in utero may be less dire
than anticipated on the basis of the earlier infant studies, the more re-
cent longitudinal studies suggest that it would be a mistake to assume
that prenatally exposed children are not at risk. A common theme in the
literature is that cocaine exposure rarely occurs in isolation. Adding to
the biological risks of both prenatal exposure to cocaine and prenatal
exposure to other substances that are frequently used with cocaine, en-
vironmental factors have been found to ‘‘play a decisive part in deter-
mining development—either helping the child to overcome the [bio-
logical] vulnerability [created by prenatal exposure] or placing the child
at greater risk of harm’’ (Mathias 1992, p. 14). Children who have nei-
ther experienced multiple child welfare placements nor continued to
live with drug addicted mothers have been shown to have more positive
outcomes than those living in homes where there is continued drug use
(Griffith, Azuma, and Chasnoff 1994).16 In contrast, prenatally exposed
children often develop poorly when faced with inadequate care from a
mother whose functioning is affected by the ‘‘stress and chaos’’ that are
associated with long-term drug abuse (Mathias 1992, p. 15). Studies have
found that prenatal exposure and the postnatal environment have simi-
lar effects on the intelligence of 3 year olds (Azuma and Chasnoff 1993)
and that maternal postpartum drug use is correlated with IQ and behav-
ioral problems for children at age 6 (Chasnoff et al. 1998).
Barry Zuckerman and Deborah Frank caution that the ‘‘biologic vul-
nerability’’ presented by prenatal exposure ‘‘may render a child more
vulnerable to the effects of poor caretaking’’ (Zuckerman and Frank
1992, p. 337). They cite studies of both opiate-exposed children and
other children with potential nervous-system vulnerabilities in which
family stability, responsive caretaking, and the quality of the postnatal
environment were found to be significant predictors of developmental
outcomes. Thus, poor caregiving environments may help to explain
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many of the poor developmental outcomes that have been observed
among prenatally exposed children, while appropriate, responsible care-
giving environments may help to compensate for the effects of exposure
by significantly improving such outcomes. In short, the use of crack co-
caine not only affects children directly through prenatal exposure but
also indirectly through its adverse effects on both parenting behaviors
and the families and communities in which these children live (Mayes
et al. 1992).
At the same time, there is also some evidence that early intervention
can make a difference for these children. Studies have found that pre-
natally exposed children who have access to early interventions, and for
whom other major risk factors have been reduced, seem completely nor-
mal in terms of intellectual, social, emotional, and behavioral develop-
ment at age 3 (Chasnoff 1992; Griffith 1992). The other major risk fac-
tors include inadequate prenatal care, inadequate prenatal nutrition,
continued parental drug use, potential postnatal drug exposure, chaotic
lifestyles (which may be further complicated by poverty), inconsistent or
inadequate parental caregiving, multiple caregivers or placements, and
maternal depression. Interventions such as substance-abuse treatment
and early home visiting, combined with appropriate social service refer-
rals, may help to reduce these risk factors.17 For instance, drug treatment
during pregnancy may lead to greater participation in prenatal care ac-
tivities as well as to improved prenatal nutrition. Furthermore, drug
treatment during and after pregnancy may reduce parental drug use af-
ter birth and, consequently, the risk of postnatal drug exposure. It is also
reasonable to expect that reduced parental drug use, in combination
with early home visiting or similar in-home interventions, may result in
less chaotic lifestyles, improved caregiving, reduced numbers of child
protective services interventions and foster care placements, and de-
creased maternal depression. Finally, referral to appropriate social ser-
vices may help mediate the socioeconomic problems, such as poverty
and unemployment, that may place many substance-abusing and child-
welfare-involved families at a further disadvantage. Appropriate social
services referrals may also afford prenatally exposed children greater ac-
cess to specialists who may aid them in reducing the effects of those bio-
logical vulnerabilities (e.g., cognitive, behavioral, emotional, and verbal)
that may be related to prenatal exposure.
Thus, we can tentatively conclude, drawing on our still limited knowl-
edge of the long-term effects of prenatal exposure to crack cocaine, that
such exposure may indicate that a family is in need of intervention and
is at risk of drawing child protective services attention, which may result
in foster care placement.18 At the same time, there is evidence to suggest
that children who are exposed to cocaine prenatally could benefit from
early assessment and intervention.
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The Child Welfare Response
As our knowledge about cocaine-exposed children has evolved, so too
has the response of the child welfare system. The influx of cocaine-
exposed children has affected the child welfare system in many ways.19
When the full impact of the crack epidemic began to crystallize in the
late 1980s, observers like Douglas Besharov called it the ‘‘single toughest
issue facing child welfare agencies’’ (Besharov 1989, p. 7). And, although
cocaine use seems to have plateaued in the 1990s, the number of chil-
dren affected—and their impact on the child welfare system—are still
staggering. Besharov (1996) estimates that about the same number of
children—between 30,000 and 65,000—were born prenatally exposed
to cocaine in 1994 as in 1987. These children constitute a large share of
the child welfare caseload. A 1994 General Accounting Office study of
young foster children in California, New York, and Pennsylvania, for in-
stance, found that two-thirds had been prenatally exposed to drugs or
alcohol, compared to only about 25 percent 5 years earlier (U.S. General
Accounting Office 1994).
How has the child welfare system responded to the children exposed
to cocaine in utero, and given what we now know about these children,
how should the child welfare system respond? Here we look at two key
aspects of the system’s response: legislation regarding reporting and leg-
islation regarding testing or screening. We focus on these two aspects of
child welfare policy because legislation regarding reporting and testing
or screening has been considered by many states, and by the Congress,
as a first step in responding to the problem of crack babies.20
Current Status of Laws regarding Reporting and Testing or Screening
All states have mandatory reporting laws that both define child abuse
and neglect and require doctors, teachers, and other professionals who
come into contact with children to report suspected cases to CPS. In
many states, infant drug addiction at birth has long been considered a
reportable type of abuse or neglect. Thus, when the crack epidemic first
hit and children were born prenatally exposed to crack cocaine, a natu-
ral response on the part of the child welfare system was to revise report-
ing laws to require filing an abuse-and-neglect report when a child was
born having been prenatally exposed to cocaine, as evidenced by a posi-
tive toxicology test (often referred to as a positive ‘‘tox’’ or ‘‘toxic
screen’’) or withdrawal symptoms at birth. By 1990, six states had passed
such laws (National Center for Youth Law 1995). Illinois, for instance,
required doctors to report any child who tested positive for drugs at
birth. Minnesota went beyond the Illinois model by also requiring that
physicians report positive drug tests on pregnant women. Between 1990
and 1995, several additional states—including Iowa, Wisconsin, and In-
38 Social Service Review
diana—amended their reporting laws to require that drug-exposed new-
borns be reported. Other states explicitly decided that positive toxic
screens would not require the filing of a report. California passed a law
to this effect in 1995, while New York simply changed its policy in 1990.
At the present time, although several states require that drug-exposed
newborns be reported to child protective services, only Minnesota re-
quires certain newborns to be tested for exposure to illicit drugs. In all
other states, testing is discretionary, and rules regarding testing are estab-
lished by hospitals and physicians. Whether it would be advantageous to
move toward more uniform policies with regard to testing is controver-
sial. A few years ago, then Representative Susan Molinari proposed leg-
islation in Congress that would have required all newborns to be tested
for substance exposure. This bill was opposed by child welfare groups
and was never enacted; however, similar proposals may be made in the
future.
An alternative to mandatory testing, proposed by Chasnoff, is that
primary-care physicians screen every family with infants or young chil-
dren as a means of promoting early detection of exposure. He recom-
mends that whenever an infant or young child is born with or presents
with a positive urine toxicology or whenever a young child’s family is
identified as abusing alcohol or illicit drugs, the family be referred for
appropriate treatment but not referred to CPS unless the family refuses
or fails to comply with treatment (Chasnoff 1998). This proposal has nu-
merous advantages over a testing proposal but is also not entirely prob-
lem free, as we address below.
Should testing be mandated for all newborns? Is screening a better
option? How should the system respond if a child tests or screens posi-
tive? Is mandatory reporting to CPS a sensible response, or would a first
response by someone other than CPS be preferable? Drawing on what
we now know about outcomes for cocaine-exposed children, we consider
these questions below.
Should Testing Be Mandated for All Newborns?
There are many arguments to be made in favor of universal testing for
all newborns.21 The current system, in which newborns are tested only if
the physician recommends it, surely misses many children who are ex-
posed to substances and who, if identified, could benefit from early in-
tervention and treatment. Furthermore, the current system is inequi-
table: poor and minority children are much more likely to be tested even
though nonpoor and white children are about equally as likely to be ex-
posed to drugs or alcohol. Since a positive test result, at least under the
current system, usually leads to involuntary state intervention, it matters
whether or not families are inequitably subjected to that intervention.
There are also many arguments against universal testing. First, a test-
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ing system, if not perfect, could turn up false positives (cases that test
positive when a child is not substance exposed). Such cases would, under
the current system, receive unnecessary and undesirable intervention
from CPS. An imperfect system could also produce false negatives (cases
that test negative when a child is substance exposed), which would result
in some children missing out on interventions that they should have re-
ceived. In deciding whether testing makes sense, then, it is important to
know how reliable the tests are likely to be. It is also important to know
what size the exposed population is likely to be, as that factor also affects
the shares of false positives and false negatives that are likely to occur.
Following the framework set out by Richard Light (1973) in his analy-
sis of child protection policies, we use probability theory to evaluate
whether testing could be sufficiently reliable given our knowledge of the
accuracy of existing tests and the incidence of prenatal exposure. In this
framework, the effectiveness of a national testing policy primarily de-
pends on the following three factors: (1) the level to which our instru-
ments can accurately identify instances in which exposure has occurred,
(2) the level to which our instruments can accurately identify instances
in which exposure has not occurred, and (3) the national incidence of
prenatal exposure.
We have no firm data with which to predict the abilities of potential
testing instruments to accurately identify both exposure and nonexpo-
sure. Therefore, we use a range of possibilities to investigate the ways in
which different levels of testing accuracy affect the proportion of error
that would result if a national testing policy were to be implemented. In
order to do this, let us assume that our testing instruments will correctly
identify exposure between 70 percent and 99 percent of the time. We
will call this proportion P(E). We will also assume that our instruments
will correctly identify nonexposure between 80 percent and 99 percent
of the time.22 We will call this proportion P(N). Finally, since estimates
of the incidence of prenatal exposure vary so widely, we should also
look at the ways in which different incidence rates influence the effec-
tiveness of the potential policy. We will call the incidence rate P(I ).
In order to determine—at various levels of the aforementioned pro-
portions—(1) the proportion of children who are actually prenatally ex-
posed and are identified as being exposed by the testing instruments,
P(P1uD1), and (2) the proportion of children who are actually exposed
but are not identified by the testing instruments as being exposed,
P(P1uD2), we use Bayes’s Theorem as follows:
P(P )P(D uP )1 1 1P(P uD ) 51 1 P(P )P(D uP ) 1 P(P )P(D uP )1 1 1 2 1 2
P(P )P(D uP )1 2 1P(P uD ) 5 ,1 2 P(P )P(D uP ) 1 P(P )P(D uP )1 2 1 2 2 2
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where
P(P1) 5 proportion of children who are prenatally exposed;
P(P2) 5 proportion of children who are not prenatally exposed;
P(D1) 5 proportion of children who are identified as prenatally
exposed;
P(D2) 5 proportion of children who are not identified as prenatally
exposed;
P(D1uP1) 5 proportion of children identified as prenatally exposed
given that they are actually exposed;
P(D1uP2) 5 proportion of children identified as prenatally exposed
given that they are not actually exposed;
P(P1uD1) 5 proportion of children who are actually exposed given
that they are identified as exposed;
P(P1uD2) 5 proportion of children who are actually exposed given
that they are not identified as exposed.
Since P(E) is equal to the proportion of exposed children who are
correctly diagnosed at first testing, P(N) is equal to the proportion of
nonexposed children who are correctly diagnosed at first testing, and
P(I ) is equal to the proportion of children who are born prenatally drug
exposed, the following substitutions can be made:
P(I )P(E)
P(P uD ) 51 1 P(I )P(E) 1 [P(1 2 P(I )) 3 P(1 2 P(N ))]
P(I )P(1 2 P(E))
P(P uD ) 5 .1 2 P(I )P(1 2 P(E)) 1 (P(1 2 P(I )) 3 P(N ))
By substituting various levels of P(E), P(N), and P(I ) into this equation,
we can compute the proportions displayed in table 1 and table 2.
The figures on these tables provide appropriate probabilities for evalu-
ating the potential effects of a national testing policy. For example, as-
suming that the instruments used for testing are precise, we could set
P(E) at .95, indicating that exposure is correctly detected 95 percent of
the time. We could also set P(N) at .99, indicating that nonexposure is
correctly detected 99 percent of the time. We consider several alternative
incidence rates. We begin with an example that uses a moderate inci-
dence rate, which we set at 5 percent because it is estimated that between
1 percent and 10 percent of newborns (between 45,000 and 375,000 of
the approximately 3.9 million children born annually) are exposed to
cocaine in utero. In the next example, we reduce our estimated inci-
dence rate to 1 percent, which may be more accurate for a low-incidence
hospital or practice. In our final example, we estimate the incidence rate
at 15 percent, which, while it is beyond the upper bound of most national
Prenatal Cocaine Exposure 41
estimates of prenatal cocaine exposure, has been reported at high-risk
hospitals.23 In addition, we show in the tables (but do not discuss in the
text) two more extreme examples of very low and very high incidence
rates (0.1 percent and 25 percent, respectively).
In our first example, assuming a moderate incidence of exposure, we
could estimate P(I ) at .050, indicating a 5 percent incidence rate. The
number in table 1 that corresponds to these figures is .8333. This means
that over 83 percent of the children identified as prenatally exposed
would actually be exposed. If this were the case, the policy would result
in false positives almost 17 percent of the time. Falsely identifying ap-
proximately 17 of every 100 children as having been prenatally drug ex-
posed appears high and may or may not be an acceptable level of error.
(The level of acceptability of error would partly depend on what happens
once a child is identified as being exposed. This issue will be discussed
in the next section.) At the same time, table 2 reveals that, under these
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Table 1
Proportion of Children Identified as Prenatally Exposed at First Testing
Who Are Actually Exposed
P(I)
.001 .010 .050 .150 .250
P(E) 5 .70:
P(N) 5 .80 ..........
P(N) 5 .90 ..........
P(N) 5 .95 ..........






















P(N) 5 .80 ..........
P(N) 5 .90 ..........
P(N) 5 .95 ..........






















P(N) 5 .80 ..........
P(N) 5 .90 ..........
P(N) 5 .95 ..........






















P(N) 5 .80 ..........
P(N) 5 .90 ..........
P(N) 5 .95 ..........






















P(N) 5 .80 ..........
P(N) 5 .90 ..........
P(N) 5 .95 ..........





















Note.—P(E) 5 proportion of exposed children who are correctly diagnosed at first test-
ing; P(N) 5 proportion of nonexposed children who are correctly diagnosed at first testing;
P(I) 5 proportion of children who are born prenatally exposed.
assumptions, there is less than a 1 percent chance (.0027) of producing
false negatives or failing to identify children who are actually exposed.
Using another example, if we again assume that P(E) and P(N) are .95
and .99, respectively, and that P(I ) is more likely to be .01, as may be the
case in a low-incidence hospital or practice, then the corresponding fig-
ure in table 1 is .4897. This means that over half of the children that the
testing process would identify as exposed really would not have been ex-
posed. This is certainly an unacceptable level of error. What should be
noted, moreover, is that in this scenario, the probability of false-positive
diagnoses would exceed that of accurate diagnoses. This is because, as
the estimated incidence rate decreases, even relatively small error rates
in our testing instruments result in a large number of false-positive iden-
tifications. As indicated in table 1, only the combination of extremely
precise methods for detecting both exposure and nonexposure and a
relatively large incidence rate results in levels of error that may be ac-
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Table 2
Proportion of Children Not Identified as Prenatally Exposed at First Testing
Who Are Actually Exposed
P(I)
.001 .010 .050 .150 .250
P(E) 5 .70:
P(N) 5 .80 ..........
P(N) 5 .90 ..........
P(N) 5 .95 ..........






















P(N) 5 .80 ..........
P(N) 5 .90 ..........
P(N) 5 .95 ..........






















P(N) 5 .80 ..........
P(N) 5 .90 ..........
P(N) 5 .95 ..........






















P(N) 5 .80 ..........
P(N) 5 .90 ..........
P(N) 5 .95 ..........






















P(N) 5 .80 ..........
P(N) 5 .90 ..........
P(N) 5 .95 ..........





















Note.—P(E) 5 proportion of exposed children who are correctly diagnosed at first test-
ing; P(N) 5 proportion of nonexposed children who are correctly diagnosed at first testing;
P(I) 5 proportion of children who are born prenatally exposed.
ceptable. Again, however, the number of false-negative errors that would
occur is very low (.05 percent). The number of false-negative identifica-
tions resulting from a national testing policy may, in fact, be too high
only if the prenatally exposed population is very large and our measuring
instruments are relatively inaccurate.
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Even if we assume that we could identify both exposure and nonex-
posure with 99 percent accuracy and even if the incidence of exposure
was as high as 15 percent, as may be the case in a high-incidence hospital
or practice, a national testing policy would still identify about five chil-
dren out of 100 as being prenatally exposed when they are not. Only
.18 percent of exposed children would be falsely identified as nonex-
posed given these proportions.
Implications for Child Welfare Policy
While the information presented here suggests that a national prenatal
exposure testing policy has very little chance of being effective given our
current estimates of incidence rates and testing accuracy, this may not
necessarily be the case. Instead, we must balance the evidence that early
identification and intervention may help to improve prenatally exposed
children’s developmental outcomes with the possibility that a national
testing policy would result in a large proportion of false positives. While
this analysis indicates that a national testing policy can not be the only
method of identifying prenatally exposed children, it could certainly
constitute one stage of a multistage process for doing so (as we discuss in
the following section). As Light (1973) suggests, the first stage of such a
process would focus on not missing real cases of exposure (not produc-
ing false negatives), while other stages would employ more stringent cri-
teria for minimizing the number of false positives. Minimizing false pos-
itives becomes extremely important when such errors result in adverse
legal and child welfare outcomes for the families involved. In many
states, when a child is identified as having been prenatally exposed, one
of three outcomes is likely to occur: (1) a child welfare investigation
is initiated, (2) the child is removed from the home, or (3) criminal
charges are brought against the birth mother. Whether or not we agree
that these outcomes are appropriate under circumstances in which there
is actual exposure, the possibility that a family would face such outcomes
when exposure has not occurred must be held to an absolute minimum.
Is Screening a Better Option?
Many of the same arguments that have been made either for or against
testing apply to screening as well. However, many physicians see screen-
ing as a better option. Is this the case? Many factors (such as ease of
administration, accuracy, and cost) may influence which method and,
indeed, which specific instrument is chosen, and other factors may play
a significant role in the debate over such policies.24 However, when we
consider the question in light of the framework used above, it becomes
clear that screening is a preferred option only if (1) its results are likely
to be more accurate than those of testing (or equally accurate but at a
reduced cost) or (2) screening can be used as a first stage of a multistage
testing strategy.
Would screening be more accurate? Drug and alcohol treatment pro-
fessionals endorse the use of screening instruments such as the Sub-
stance Abuse Subtle Screening Inventory (SASSI) and claim that it can
correctly identify substance abuse in 94 percent of cases. Current best
estimates also suggest that screening instruments such as the SASSI
might also incorrectly identify substance abuse—that is, produce false
positives—in about 6 percent of cases.25 These figures suggest that a
screening instrument, such as the SASSI, would do better than testing at
identifying substance-exposed newborns if we assume that tests correctly
identify 95 percent of substance-exposed newborns but that they in-
correctly identify 11 percent of nonexposed newborns (Schwartz et al.
1990).26
However, it may be incorrect to think of screening merely as an alter-
native to testing. With regard to newborns, screening and testing could
be complementary policies. For instance, a medical practice might first
screen all pregnant women for substance abuse and then test only those
newborns whose mothers screened positive or who showed signs of pre-
natal exposure to drugs or alcohol. (In addition, it might be prudent to
test newborns whose mothers received no prenatal care and were there-
fore never screened.)
Such a multistage policy offers several advantages. It gives the physi-
cian a chance to counsel a pregnant woman about the risks of substance
abuse and to refer her for drug or alcohol treatment if she screens posi-
tive during the pregnancy. It may also provide a better basis for deciding
which newborns should be tested at birth.27 Furthermore, there is some
evidence that pregnant women may be more likely to accurately report
their substance use if they believe that the substance-using activities that
they report (or fail to report) during the screening process will be veri-
fied via testing.28
Thus far in our discussion, we have not specified what type of interven-
tion the children identified via screening or testing should receive. We
turn to that question next.
How Should the System Respond If a Child Tests or Screens Positive?
In considering this question, it will be useful to examine separately the
two different groups of children we have discussed thus far: newborns
who test positive for exposure to cocaine and newborns whose mothers
screened positive for cocaine during the pregnancy.
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For newborns who test positive for exposure to cocaine, it is now stan-
dard practice, and indeed law in most jurisdictions, that the case is re-
ported to CPS. However, not all of these cases are substantiated for abuse
or neglect by CPS, and only a minority of the children reported are re-
moved from their mothers and placed into substitute care. This is be-
cause, in order to intervene beyond the point of an investigation, CPS
must find not only that the mother used or is using crack cocaine but
that her drug use is interfering with her ability to properly care for the
child. Some women manage to provide adequate care in spite of their
drug use, often by relying on friends or family members to provide some
care for their children.
Is Mandatory Reporting to CPS a Sensible Response?
Given the evidence presented above, it would make sense that a case
should be referred to CPS only if a child has tested positive and there are
indications that the mother cannot adequately care for him or her. (This
is not to say that infants who test positive should not be referred else-
where for services; however, CPS may not be the most sensible referral.)
All children who test positive could be referred for (1) substance abuse
treatment for the parent(s) and (2) an assessment for the child in order
to determine whether or not the child may require a developmental in-
tervention such as home visiting by a nurse or social worker trained in
early intervention with substance-exposed children.29 Physicians may
also wish to closely monitor such children in case developmental prob-
lems surface in later childhood. Cases in which there is evidence at birth
that the mother cannot adequately care for the child should continue
being referred to CPS. However, without such evidence, cases should be
referred to CPS only when the substance-abuse treatment worker or
home-health visitor have concerns that warrant protective intervention.
Such models are already in place in several communities that are
attempting to provide more sensible responses to substance-exposed
newborns and their families. Jacksonville, Florida, for instance, refers
all substance-exposed newborns to nurse home visitors with special ex-
pertise in substance abuse rather than to CPS. Chicago, Illinois, uses
a mixed strategy, whereby cases may either be referred to CPS and a
substance-abuse agency or to the substance-abuse agency alone, depend-
ing on whether the family needs both substance-abuse treatment and
protective oversight or substance-abuse treatment alone. Implementing
these different models of practice requires some degree of retraining of
child welfare, child and family service, and health-care professionals.
While a full discussion of this issue is beyond the scope of this article, we
note that cross training—whereby child welfare, child and family service,
and health-care staff are trained jointly with substance-abuse and early
interventions specialists—would be particularly helpful in this regard.30
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As we discussed earlier, screening may also be used to identify ex-
posure to cocaine before a child is born. How should those cases be
handled? For those children identified prenatally, screening presents
an excellent opportunity for a physician both to offer counsel and refer
the mother for treatment prior to giving birth. It can also provide ad-
ditional evidence to help a physician determine whether or not a child
should be drug tested at birth or monitored and referred for further as-
sessments or interventions (e.g., early intervention, home-visiting pro-
grams, substance-abuse treatment, or CPS) after birth.
Conclusion
The biological risks associated with prenatal exposure to crack cocaine
are, thankfully, less severe than was first thought when crack cocaine
burst onto the scene a little over a decade ago. Yet there is still substantial
evidence for concern about children who are prenatally exposed to co-
caine, particularly if they continue to live with a drug-using parent after
birth. Identifying prenatally exposed children and providing them with
appropriate interventions are sound policies, although not all means to
this end are equally effective. As our analysis reveals, universal testing is
one of the least promising policy alternatives. In contrast, more wide-
spread screening of pregnant women and newborns—with the option of
testing only those newborns whose mothers were identified as likely sub-
stance users through a screening instrument, who exhibit withdrawal
symptoms, or who received no prenatal care—makes a good deal of
sense. We do not, however, recommend that all children identified via
screening or testing be referred to child protective services. The first line
of defense in parental substance-abuse cases should be substance-abuse
treatment services and, when there is additional evidence that a child’s
development may be compromised, assessment and referral to early
intervention specialists such as home visitors. Child protective services
should be involved only in those cases in which parents either refuse to
participate in such services and, as a result, their children’s well-being is
compromised or where parents are unable to provide adequate caregiv-
ing, even after receiving services.
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1. There is a wide range of estimates regarding the number of children who are exposed
to crack cocaine in utero, and none of the estimates are considered completely reliable
(see Robins and Mills 1993; Frank, Bresnahan, and Zuckerman 1996).
2. Parental substance abuse has been linked to child abuse and neglect reports and to
repeat reports. Substance-exposed children enter care at higher rates and at younger ages,
experience a greater number of placements, and remain in care longer than nonexposed
children. And children whose parents use drugs are less likely to return home from foster
care than those whose parents do not use drugs (Regan, Ehrlich, and Finnegan 1987; Gus-
tavsson 1991; Famularo, Kinscherff, and Fenton 1992; Barth 1994; Horn 1994; Walker 1994;
Barth and Needell 1996; Wolock and Magura 1996).
3. The 1991 National Household Survey on Drug Abuse found that 12.9 million children
(18.8 percent of all children) had a parent who had used drugs in the past year, including
6.2 million children (9.2 percent of all children) whose parent had used drugs in the past
month (see U.S. Department of Health and Human Services 1994, p. 39). Data from the
National Institute on Drug Abuse (1994) suggest that over 1 million children are prenatally
exposed to alcohol or illicit substances each year.
4. According to the 1991 National Household Survey on Drug Abuse, 10.8 percent of
0–2-year-olds had a parent who had used drugs in the past month, a rate only slightly higher
than that for children of all ages (9.2 percent).
5. The term ‘‘bio-underclass’’ was used by the Washington Post, September 17, 1989 (cited
in Myers et al. 1992, p. 2). Others used the term ‘‘biologic underclass’’ (see, e.g., Toufexis
1991).
6. It should also be noted that publication biases have been cited in the literature indi-
cating that studies that result in adverse findings related to exposure have been shown to
have a greater chance of being published than studies that do not (Robins and Mills 1993;
Neuspiel 1995; Frank et al. 1996).
7. With the exception of Graham et al. (1992), all of the current studies have focused on
low-income women and children, while allowing for the possibility that other conditions of
poverty have influenced findings.
8. While substance-use rates have been shown to be similar among black and white preg-
nant women, black women are more likely than white women to be reported to the authori-
ties for substance use during pregnancy (Chasnoff, Landress, and Barrett 1990). Further-
more, minority children are more likely than white children to enter the child welfare
system due to parental substance use (Gustavsson 1991).
9. See also the description of a crack-addicted mother in Massing (1998), pp. 29– 46.
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10. Lester, LaGasse, and Bigsby (1998) found in their review of 76 studies that only three
had used meconium testing.
11. Chasnoff et al. (1989) found improved in utero growth for exposed children whose
mothers discontinued use after the first trimester of pregnancy. Furthermore, Hutchings
(1993) suggests that the adverse teratogenic effects of prenatal exposure may occur only
for those infants who are exposed to the highest doses of cocaine.
12. Jacobson et al. (1994) explain that cocaine exposure tends to affect birth size
(weight, length, and head circumference) indirectly as a consequence of shorter gestation
and poor maternal nutrition. Other studies have found few differences in length, weight,
and head circumference between exposed and nonexposed infants born preterm (Collett
1997) and no differences in intrauterine growth between exposed and nonexposed infants
(Chasnoff et al. 1985).
13. Frank and Zuckerman (1993) conclude that birth defects are relatively rare among
crack-exposed infants. Furthermore, Richardson and Day (1994) report that, controlling
for socioeconomic variables and other drug use, prenatal cocaine exposure appears not to
affect infant growth and morphology significantly.
14. The one study that found differences in cognitive development was van Baar and
de Graaff (1994).
15. Lester, LaGasse, and Seifer (1998) further explored these differences in their met-
analysis. Of the 101 studies that met their inclusion criteria, only eight focused on school-
age children. They conclude that, when considered together, these eight studies suggest
that cocaine exposure may result in subtle negative effects on IQ and slightly larger nega-
tive effects on specific language abilities. The researchers estimate that these subtle forms
of brain damage will increase the number of children who need special education or fail
in school, which could result in additional education costs of up to $352 million per year.
16. Furthermore, Zuckerman and Frank (1994) interpret the findings of Singer et al.
(1994) as suggesting that the combination of prenatal exposure and foster care placement
may result in greater risks for children than either factor alone.
17. For a further discussion of the effectiveness of home visiting, see Future of Children
(1993) and Future of Children (1999), both special issues devoted to home visiting. For an
overview of the evidence on the efficacy of substance-abuse treatment services, see Gerstein
and Harwood (1990); Rydell and Everingham (1994); and U.S. Department of Health and
Human Services (1996).
18. Current evidence suggests that substance-exposed infants are more likely to enter
care than are other children. Richard P. Barth (1994) reports that 80 percent of children
who were both born prenatally exposed to illicit substances and known to the child welfare
system were placed in foster care in 1990. Chasnoff (1998) cites the U.S. General Account-
ing Office in reporting that 55 percent of the very young children placed in substitute care
in 1991 were prenatally exposed to some form of cocaine and that an additional 11 percent
were prenatally exposed to alcohol or other drugs.
19. For an excellent overview of the impact of parental substance abuse on the child
welfare system, see U.S. General Accounting Office (1997).
20. The other way in which state legislatures and Congress have responded is by chang-
ing regulations regarding permanency planning for children exposed to crack cocaine or
other substances. We intend to review these initiatives in future work; to cover them here
would be beyond the scope of this article.
21. Drug exposure can be tested through both laboratory tests and on-the-spot tests,
which may measure the presence and amount of a specific substance in various samples,
including urine, blood, hair, and saliva. Some tests, commonly referred to as qualitative
tests, identify only whether or not a specific substance is present or absent at a predeter-
mined concentration in a given sample. Quantitative tests, however, show both the pres-
ence and quantity (concentration) of a specific substance in a given sample (Roche Diag-
nostics 1999).
22. It is probably safe to make these assumptions because it is not likely that less accurate
instruments would be useful for testing. Furthermore, urine testing is one of the most com-
monly used tests, and Schwartz, Bogema, and Thorne (1990) report that one enzyme im-
munoassay urine test, the EZ-SCREEN, had a sensitivity (ability to accurately identify expo-
sure in exposed children) of 95 percent, a specificity (ability to identify nonexposure in
nonexposed children) of 89 percent, and an efficiency of 87 percent for samples contain-
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ing 300 ng/mL or more cocaine metabolites. They found two false negatives (5.26 percent)
and five false positives (13.16 percent) out of 38 samples.
23. Rates as high as 30 percent have been reported at high-risk hospitals (see Harwood,
Fountain, and Livermore 1998).
24. These factors may include costs to mothers, physician or managed-care support, and
costs to the doctor/patient relationship. Both testing and screening policies may pose sig-
nificant costs to mothers in terms of loss of privacy and stigma. However, the extent to
which mothers’ privacy is invaded may be limited if the results of screening or testing are
kept confidential. In such cases, mothers could still be referred for treatment; however,
participation would be on a purely voluntary basis, and substance exposure status would not
be reported to CPS or any other source. A confidentiality policy may also limit stigma re-
garding substance-using pregnant women, as their substance-abuse statuses would only be
known by their primary-care physicians. If, however, positive results were not kept confiden-
tial, one could argue that screening is less invasive than testing in regard to maternal pri-
vacy, because in the case of screening, mothers may believe that they have greater control
over what they choose to disclose. In regard to physician or managed-care support, both
groups may be more likely to support screening, as it is much less costly than testing and is
easy to administer. The SASSI, for instance, costs about two dollars per administration, can
be administered in paper or computer form (or orally) by almost anyone, is readable at the
fifth-grade level, and can be completed in 10–15 minutes and scored in 1–10 minutes.
Furthermore, it is ‘‘insulated to the respondent’s level of honesty or faking’’ (Vacc 1994,
p. 252). By comparison, while many urine-based drug tests can be easily administered in a
physician’s office, their cost of administration is about two to 10 times that of the SASSI
(approximately $5–$20 per administration, depending on the number of drugs being
tested). In addition, the SASSI offers the added benefit of testing for substance addiction
in general rather than for the presence of specific drugs. It therefore identifies alcohol
addiction, which is not generally picked up in toxicology tests. The SASSI has also been
found to be more effective and less costly at identifying substance abuse than has toxicology
testing (Horrigan, Piazza, and Weinstein 1996). Finally, although the doctor/patient rela-
tionship may be adversely affected under either screening or testing, the overall effect on
the relationship may be more heavily influenced by reporting requirements (i.e., policies
regarding confidentiality of results) than by the method of determining substance abuse.
Each of these factors should be considered by policy makers when considering the costs
and benefits of screening and testing policies.
25. The SASSI Institute (1998) reports that the SASSI-3 has a sensitivity of 94 percent
and a specificity of 94 percent.
26. For the purposes of this analysis, we assume that qualitative, on-the-spot urine tests
would most likely be used for national screening. We make this assumption for several rea-
sons: (1) they are less expensive and easier to administer than other tests, (2) there is a
large amount of empirical data regarding these tests, (3) many commercial tests of this type
are available (e.g., the EZ-SCREEN, OnTrak, and Verdict tests), (4) drugs are both more
highly concentrated and detectable over longer periods of time in urine than in blood, and
(5) urine is relatively easy to collect and analyze as compared to many other sample types
(Roche Diagnostics 1999).
27. Although the topic of this article is children who are prenatally exposed to cocaine,
we should note that screening also has potential as a strategy to identify the larger group of
children who have been prenatally exposed to other drugs or alcohol as well as children
other than newborns who are affected by parental substance abuse. According to the Na-
tional Institute on Drug Abuse (1994) report on substance abuse among parents, about
one in five American children had a parent who used drugs in the past year. Furthermore,
the National Institute on Drug Abuse reports that more than 1 million children are born
prenatally exposed to illicit drugs or alcohol each year. This figure represents more than a
quarter of all births. Thus, if we were to extend our analysis to substance exposure more
generally, we could safely use a value of 20–25 percent for P(I ) in our analysis.
28. See, e.g., Lowe et al. (1986).
29. A complete discussion of home visiting, while important, is beyond the scope of this
article. For a further discussion, see Future of Children (1993) and Future of Children (1999),
which are special issues devoted to home visiting.
30. For further discussion of cross training and other training issues, see Waldfogel
(1998).
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